Bone-targeting exosome nanoparticles activate Keap1 / Nrf2 / GPX4 signaling pathway to induce ferroptosis in osteosarcoma cells

Wenkai Chen,Zongguang Li,Naichun Yu,Linlin Zhang,Hongyu Li,Yongjie Chen,Fengqing Gong,Wenping Lin,Xu He,Siyuan Wang,Yue Wu,Guangrong Ji
DOI: https://doi.org/10.1186/s12951-023-02129-1
IF: 10.2
2023-10-01
Journal of Nanobiotechnology
Abstract:In recent years, the development of BMSCs-derived exosomes (EXO) for the treatment of osteosarcoma (OS) is a safe and promising modality for OS treatment, which can effectively deliver drugs to tumor cells in vivo. However, the differences in the drugs carried, and the binding of EXOs to other organs limit their therapeutic efficacy. Therefore, improving the OS-targeting ability of BMSCs EXOs and developing new drugs is crucial for the clinical application of targeted therapy for OS.
biotechnology & applied microbiology,nanoscience & nanotechnology
What problem does this paper attempt to address?